Nicholas Bosch is a Respiratory physician affiliated with Boston University. OpenAlex indexes 195 publications with 2,087 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
725 Albany St, Suite 9b
Shapiro Bldg
Boston, MA 021182526
Telephone
617-638-7480Provider last certified this registry record 8 Jun 2023.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
82.8%beta2-Adrenergic Agonist25%Ventolin Hfa60%Proair Hfa40%Part D<11 patientsAnticholinergic22.8%Incruse Ellipta100%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
9.4%Corticosteroid9.4%Prednisone100%Part D<11 patientsAnti-infectives
7.8%Macrolide Antimicrobial7.8%Azithromycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- A Learning Health System Approach to Improve the Effectiveness of Blood Transfusions during Septic Shock
Boston University Medical Campus
FY2026$169,452K23HL173709 - A Learning Health System Approach to Improve the Effectiveness of Blood Transfusions during Septic Shock
Boston University Medical Campus
FY2025$172,152K23HL173709 - A Learning Health System Approach to Improve the Effectiveness of Blood Transfusions during Septic Shock
Boston University Medical Campus
FY2024$172,152K23HL173709
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effectiveness of Fludrocortisone Plus Hydrocortisone versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
American Journal of Respiratory and Critical Care Medicine
2024 - Evaluation of Etomidate Use and Association with Mortality Compared with Ketamine among Critically Ill Patients
American Journal of Respiratory and Critical Care Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Holick, MD
Boston University
Gene Kwan, MD
Boston University
Joseph Antin, MD
Boston University
George O'Connor, MD
Boston University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”